A new lawsuit against Optimal Blue raises a defining question for the digital mortgage era: when does data transparency enhance competition, and when does it cross into coordination?

The Colorado Bureau of Investigation announced the findings on Friday of an internal affairs investigation into a former CBI DNA scientist who has been accused of data manipulation of DNA test results ...

Drug manufacturer Intas Pharmaceuticals is no stranger to FDA scrutiny. Now, one of its plants has been placed on an import alert after a series of interactions with the agency. After a May inspection ...